Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V4MB
|
||||
Former ID |
DCL000619
|
||||
Drug Name |
Remogliflozin etabonate
|
||||
Synonyms |
GSK-189075; GSK-189075A; KGT-1681
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Type 1/2 diabetes [ICD9: 250, 278; ICD10:E08-E13] | Phase 2 | [548088] | ||
Company |
GSK
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H38N2O9
|
||||
Canonical SMILES |
CCOC(=O)OCC1C(C(C(C(O1)OC2=NN(C(=C2CC3=CC=C(C=C3)OC(C)C<br />)C)C(C)C)O)O)O
|
||||
InChI |
1S/C26H38N2O9/c1-7-33-26(32)34-13-20-21(29)22(30)23(31)25(36-20)37-24-19(16(6)28(27-24)14(2)3)12-17-8-10-18(11-9-17)35-15(4)5/h8-11,14-15,20-23,25,29-31H,7,12-13H2,1-6H3/t20-,21-,22+,23-,25+/m1/s1
|
||||
InChIKey |
UAOCLDQAQNNEAX-ABMICEGHSA-N
|
||||
CAS Number |
CAS 442201-24-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Sodium/glucose cotransporter 2 | Target Info | Blocker | [550963] | |
WikiPathways | NRF2 pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.